baber/WOPTO huggingface dataset:
Patent NZ-338065-A (NZ)
Title: Prolonged release formulation of GM-CSF dispersed in a polymeric hydrogel
Inventor: GOMBOTZ WAYNE
IPC: A61K38/19
Filed: 1996-10-10
Abstract: Described is a formulation for controlled delivery of GM-CSF.  The GM-CSF is dispersed in a synthetic polymeric hydrogel which absorbs water up to 90% of the final weight of the hydrated hydrogel. The hydrogel is preferably alginate, a polyphosphazene, a polyacylate, a polyethylene oxide-polypropylene glycol block copolymer and hyaluronic acid.
Patent NZ-501713-A (NZ)
Title: Single step synthesis gas-to-dimethyl ether process with methanol introduction
Inventor: PENG-XIANG-DONG
IPC: C07C41/01
Filed: 1999-12-10
Abstract: A process for converting hydrogen and carbon monoxide into dimethyl ether and methanol in a single step process comprising contacting the hydrogen and carbon monoxide with a bifunctional catalyst system having a methanol synthesis functionality and a methanol dehydration functionality in a dimethyl ether reactor and introducing a methanol containing stream into the reactor such that the methanol concentration throughout the reactor is greater than 1.0% and wherein the methanol comprises make-up methanol.
Patent NZ-507687-A (NZ)
Title: Drawer matching the corner profile of a cabinet
Inventor: MURDOCH STEPHEN JOHN
IPC: A47B88/00
Filed: 2000-10-20
Abstract: A corner storage compartment for a cabinet or joinery unit consisting of an open top boxlike container that follows the contours of both the back corner and front of the cabinet as shown in fig 2. The unit slides in and out horizontally on a frame or track and has front-end surface finish to match the rest of the joinery unit or cabinet, with handles to help facilitate the movement of the container. This container is much like a drawer, but adapted to fit in a corner. Also described is a joinery unit consisting of one or more of these containers.
Patent NZ-508037-A (NZ)
Title: A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
Inventor: STUPAK ELLIOT I
IPC: A61K31/445
Filed: 1999-05-27
Abstract: Described is a syrup formulation comprising: At least one antihistamine selected from the group consisting of loratadine, descarboethoxyloratadine or azatadine, and About 0.05 to about 5 mg/mL of at least one aminopolycarboxylic acid or salt thereof, and Optionally at least one decongestant, analgesic, antitussive or expectorant.
Patent NZ-513747-A (NZ)
Title: Bone plate with conical screw threads
Inventor: SCHAVAN ROBERT
IPC: A61B17/80
Filed: 1999-03-09
Abstract: A bone plate with a top surface (1), a bottom surface (2) for contact with the bone and several holes (4) which are situated along the longitudinal axis of the plate, connecting the top surface and the bottom surface (1, 2), for receiving bone screws (11). The diameter DL of at least one of these holes (4) is greater in the direction of the longitudinal axis of the plate (3) than the diameter DQ of said hole vertically in relation to the longitudinal axis of the plate (3). At least one of the holes (4) has an inner screw thread (5). This inner screw thread (5) tapers towards the bottom surface of the bone plate. This bone plate can serve as a compression plate and as a so-called internal fixator at the same time, as effectively as if the two elements were separate.
Patent NZ-514527-A (NZ)
Title: Aqueous coating composition with improved adhesion to friable surfaces
Inventor: GEBHARD MATTHEW STEWART
IPC: C08F291/00
Filed: 2001-09-28
Abstract: Aqueous coating composition capable of adhesion to friable surfaces comprising a plurality of polymeric particles, each of said particles comprising: a) at least one polymer A having a glass transition temperature of -20°C to 100°C, wherein polymer A is an emulsion polymer comprising: i)at least one copolymerised ethylenically unsaturated nonionic monomer having a water solubility less than 8% by weight, based on the weight of water; and ii) at least one copolymerised acid monomer, such that the acid number of said polymer A is 13 to 260; and b) at least one polymer B having a glass transition temperature of -20°C to 100°C, wherein polymer B is an emulsion polymer comprising at least one ethylenically unsaturated nonionic monomer.
Patent NZ-517879-A (NZ)
Title: Novel safety condom
Inventor: TIRADO ABULLON SALVADOR
IPC: A61F6/04
Filed: 2000-06-22
Abstract: The novel safety condom consists of a body (1) formed by two compartments: a front (2) and a back (3) compartment. Said compartments are separated and independent of one another by means of a partition or septum (4) which is intended to be located in balano-preputial sulcus (9) of the penis (7), thereby forming a closed compartment (2) preventing spillage of semen.
Patent NZ-519204-A (NZ)
Title: Multiply-substituted protease variants with altered net charge for use in detergents
Inventor: POULOSE AYROOKARAN J
IPC: C11D7/42
Filed: 1998-10-23
Abstract: A method of producing a subtilisin variant that is more effective than a precursor subtilisin in a low, medium or high detergent concentration system having less than about 800 ppm, between about 800 and about 2000 ppm or greater than about 2000 ppm detergent components presenting the wash water respectively.
Patent NZ-521622-A (NZ)
Title: Measuring metabolic rate changes
Inventor: VAN DUIJN ALBERT
IPC: A01C1/02
Filed: 2001-03-16
Abstract: The application discloses a method for determining the metabolic state or a change in metabolic rate of a multicellular organism. The methodology comprises placing an organism or part thereof in a container and measuring the concentration of metabolic gas in the container to determine the consumption or production of gas by the organism. The gas concentration is determined without affecting the concentration of the gas in the container. The multicellular organism may be for example, a plant, plant part, seed or worm.
Patent NZ-523456-A (NZ)
Title: Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
Inventor: BECK JAMES P
IPC: A61K31/4741
Filed: 2001-07-11
Abstract: Selective neurotransmitter binding compounds that are useful for the treatment of various neurological and psychological disorders, e.g., ADHD are disclosed. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth in the specification.
Patent NZ-523840-A (NZ)
Title: Qualitative and quantitative measurement of toxins using in vitro cultured cells
Inventor: ROSSINI GIAN PAOLO
IPC: G01N33/53
Filed: 2001-06-29
Abstract: Described is a method for the detection, identification and measurement of toxins belonging to the group of dinophysistoxins and of yessotoxins, based upon the use of in vitro cell cultures.
Patent NZ-530837-A (NZ)
Title: Derivatives of ecteinascidin 736 as antitumoral analogs
Inventor: MARTINEZ VALENTIN
IPC: A61P35/00
Filed: 2002-08-06
Abstract: Derivatives of ecteinascidin 736 of formula (I) that may be used as antitumoral agents are disclosed, wherein: R1, R2, R3, R4 and R5 are each independently selected from the group consisting of H, OH, OR', SH, SR', SOR', SO2R', C(=O)R', C(=O)OR', NO2, NH2, NHR', N(R')2, NHC(O)R', CN, halogen, =O, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C2-C18 alkenyl, substituted or unsubstituted C2-C18 alkynyl, substituted or unsubstituted arly, substituted or unsubstituted heterocyclic; wherein X is independently selected of OR', CN, (=O), or H; R' groups is independently selected from the group consisting of H, OH, NO2, NH2, SH, CN, halogen, =O, C(=O)H, C(=O)CH3, CO2H, substituted or unsubstituted C1-C25 alkyl, substituted or unsubstituted C2-C18 alkenyl, substituted or unsubstituted C2-C18 alkynyl, substituted or unsubstituted aryl; m is 0, 1 or 2; and n is 0, 1, 2, 3, or 4.
Patent NZ-535068-A (NZ)
Title: Method and apparatus for non-invasively measuring hemodynamic parameters using parametrics
Inventor: GALLANT STUART L
IPC: A61B5/021
Filed: 2003-02-04
Abstract: An improved method and apparatus for non-invasively assessing one or more hemodynamic parameters associated with the circulatory system of a living organism. In one aspect, the invention comprises a method of measuring a hemodynamic parameter (e.g., arterial blood pressure) by applanating or compressing portions of tissue proximate to the blood vessel of concern until a desired condition is achieved, and then measuring the hemodynamic parameter. Such applanation effectively mitigates transfer and other losses created by the tissue proximate to the blood vessel, thereby facilitating accurate and robust tonometric measurement. An algorithm adapted to maintain optimal levels of applanation is also described. Methods and apparatus for scaling such hemodynamic parameter measurements based on subject physiology, and providing treatment to the subject based on the measured parameters, are also disclosed.
Patent NZ-536494-A (NZ)
Title: Bisarylsulfonamide compounds and their use in cancer therapy
Inventor: WANG SHUDONG
IPC: A61K31/43
Filed: 2003-07-07
Abstract: Disclosed are compounds of formula I and uses of compounds of formula I in the preparation of medicaments for treating proliferative disorders, wherein: W is alkylene or alkenylene, n is 0 or 1, R1 is H, alkyl, alkenyl, or optionally substituted aryl or aralkyl, and the remaining substituents are defined herein.
Patent NZ-537728-A (NZ)
Title: System and process for developing a voice application
Inventor: LAW ENG BOON
IPC: G06F40/00
Filed: 2003-07-24
Abstract: A system for use in developing a voice application includes a dialog element selector for defining execution paths of the application by selecting dialog elements and adding the dialog elements to a tree structure. Each path through the tree structure represents one of the execution paths. The system also has a means for receiving user input generated by user interaction with the dialog element selector; means for processing the user input to define a voice application by selecting dialog elements representing components of the application, configuring properties of the selected dialog elements and defining execution paths of the application as respective sequences of at least a subset of the selected dialog elements and a code generator for generating application code for the application. The application code represents each dialog element of the application as a sequence of VoiceXML elements including extended attributes to allow the tree structure of the application to be determined.
Patent NZ-540855-A (NZ)
Title: System for conducting clinical trials
Inventor: MCMAHON STEPHEN
IPC: G16H10/20
Filed: 2003-11-27
Abstract: A system 1 for conducting a clinical trial of a pharmaceutical substance on a plurality of trial participants is disclosed. The system 1 includes a central database 2 and one or more trial sites each having a remote computer 3 in communication with the central database. The central database is configured to receive predetermined parameters of the trial and both the central database and the remote computers are configured to receive predetermined trial data from one or more trial participants. Particulars of the trial participants are recorded in the database and a device, method, or substance of treatment is then assigned to randomised particulars of each trial participant. Trial data is entered to the database by an authorised trial participant. The central database is configured to control and track the ordering, allocation and dispensing of the pharmaceutical substances and compiling a pharmaceutical substance inventory record on the central database, and the central database will terminate the clinical trial in response to one or more predetermined trial termination conditions.
Patent NZ-541112-A (NZ)
Title: Cyano anthranilamide insecticides
Inventor: HUGHES KENNETH ANDREW
IPC: C07D401/04
Filed: 2004-01-21
Abstract: Disclosed are compounds of Formula I, an N-oxide or salt thereof. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent.
Patent NZ-544154-A (NZ)
Title: Macrocyclic quinazoline derivatives as antiproliferative agents
Inventor: FREYNE EDDY JEAN EDGARD
IPC: C07D239/94
Filed: 2004-05-25
Abstract: Disclosed is a compound of formula I, the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the substituents are disclosed within the specification. Also disclosed is the process for preparing the above compound and the use of the above compound in the manufacture of a medicament for treating cell proliferative disorders such as atherosclerosis, restenosis and cancer.
Patent NZ-546851-A (NZ)
Title: Multi-adhesive medical appliance designed to be removably mounted on the skin as part of an ostomy device
Inventor: ARMOUR PAUL
IPC: A61L15/58
Filed: 2004-10-29
Abstract: A medical appliance designed to adhere to the skin proximate a stoma or other open wound with an adhesive layer including two or more different composition pressure sensitive adhesives is disclosed, wherein the medical appliance comprises a film layer, a first hydrocolloid adhesive and a second hydrocolloid adhesive, wherein the second hydrocolloid adhesive has a different composition than the first hydrocolloid adhesive. One adhesive is skin friendly, having excellent tack properties, and painless removability. The other adhesive is flexible and comfortable to wear, has high moisture tolerance and the ability to swell to create a seal around the stoma. It has minimal cold flow and will not discolour significantly when sterilized. Particularly disclosed is a medical appliance having a stomal opening, the medical appliance being adherable to peristomal skin around a stoma, comprising: (a) a first hydrocolloid adhesive layer being rubber-free and having a first adhesive surface for contacting the skin, .said first hydrocolloid adhesive layer having initial wet-tack and cold flow adhesion characteristics for directly contacting and adhering to the peristomal, skin, said first hydrocolloid adhesive layer including a polyisobutylene having dispersed therein a water soluble or swellable hydrocolloid or mixture of hydrocolloids; (b) a second hydrocolloid adhesive layer overlying said first hydrocolloid adhesive layer and apart from said skin contacting first adhesive surface, said second hydrocolloid, adhesive layer including a homogeneous mixture of one or more polyisobutylenes or blends of one or more polyisobutylenes and butyl rubber, and one or more styrene radial or block type copolymers, mineral oil, one or more water soluble hydrocolloid gums and a tackifier, said second hydrocolloid adhesive layer being more flexible, having less cold flow, having greater ability to swell, and greater thickness than said first hydrocolloid adhesive layer; and (c) a film layer in contact with at least one of said first and second hydrocolloid adhesive layers.
Patent NZ-546907-A (NZ)
Title: Common point authoring system for tracking and authenticating objects in a distribution chain
Inventor: HOLCOMBE STEVEN L
IPC: G06Q10/00
Filed: 2004-09-23
Abstract: A common point authoring system functions to provide livestock informational objects via the use of a centralized repository of uniquely identified immutable livestock informational objects. The common point authoring system for maintaining data for use by authoring and accessing members to track uniquely identified products comprises: means for enabling an authorized authoring member to create data comprising a draft informational object, which uniquely identifies a product for tracking purposes; means for authenticating the draft informational object created by the authorized authoring member; means for converting the authenticated informational object created by the authorized authoring member to a corresponding immutable informational object which is identified by a unique identifier; means for writing the created immutable informational object into a memory for use by authorized accessing members and means for updating an informational object by creating a new informational object relating back to the informational object and containing new data.
Patent NZ-548312-A (NZ)
Title: Track divider used in layout of a race track
Inventor: WEST BRUCE
Filed: 2006-07-04
Abstract: A track divider for a racing track 1 , the track divider comprising a primary splitting section 3 , two or more paths, at least one island 6 and a primary blending section 46, such that competitors on the racing track enter the track divider at the primary splitting section 3, continue along one of the paths around each island and leave via the primary blending section 46. At least one path passes through one or more secondary splitting sections 32,33 after the primary splitting section and one or more secondary blending sections 40,41 before the primary blending section; such that each competitor on the racing track at each splitting section is able to independently choose which path to follow around the or each island.
Patent NZ-548985-A (NZ)
Title: Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
Inventor: JOHNSON BARBARA JANE
IPC: A61K38/17
Filed: 2005-01-14
Abstract: Provided is the use of Chaperonin 10 in the manufacture of a medicament for treating a hear disease, condition responsive to regulation of Toll-like receptor signalling in an animal in one or more cells, tissues or organs derived therefrom, wherein said medicament is capable of regulating agonist-induced Toll-like receptor signalling. Further provided is an isolated molecular complex comprising a Toll-like receptor, a Toll-like receptor agonist and Chaperonin 10 and methods of screening and producing Chaperonin 10 antagonists.
Patent NZ-549038-A (NZ)
Title: Method for control of cyanobacteria algae, mosses, liverworts, hornworts and other bryophytes
Inventor: HASHMAN THOMAS E
IPC: A01N37/10
Filed: 2005-02-09
Abstract: Disclosed is a method for controlling unwanted cyanobacteria algae, mosses, liverworts, hornworts and other bryophytes, which comprises applying an effective amount of a protophyrinogen oxidase enzyme-inhibiting herbicide, its agriculturally acceptable salts, esters, acids and metabolites to a locus where said cyanobacteria algae, mosses, liverworts, hornworts and other bryophytes are growing.
Patent NZ-549482-A (NZ)
Title: Vibration exercise machine with gas suspension
Inventor: PETERKEN NEIL TERRY
Filed: 2006-08-25
Abstract: A vibration exercise machine (1) with a controllable air suspension system is disclosed. The exercise machine includes a contact surface (2) on which a user positions themselves, a base (3), and a vibration generating element for vibrating the contact surface. Gas suspension units (5) are placed between the contact surface and base to isolate the vibration. The pressure in the suspension units may be automatically controlled.
Patent NZ-554981-A (NZ)
Title: System and method for managing the buoyancy of an underwater vehicle
Inventor: SIMPSON STEVEN M
Filed: 2007-05-07
Abstract: A system and method for managing the buoyancy of a remotely operated vehicle (ROV) (116) working at an underwater site is disclosed. A ballast tank (312) is located within the ROV (116). The ballast tank (322) communicates with a gas storage system (356) separate from the ROV via mating first and second connectors (318, 350). The ballast tank (334) is recharged by mating the first and second connectors (318, 350) and transferring gas from the gas storage system (356) to the ballast tank (334).
Patent NZ-565349-A (NZ)
Title: A method for identification, isolation and production of antigens to a specific pathogen
Inventor: MEINKE ANDREAS
IPC: C12Q1/68
Filed: 2002-01-21
Abstract: Disclosed is a hyperimmune serum-reactive antigen selected from the group consisting of (a) a polypeptide comprising an amino acid sequence set forth in SEQ ID NO:73; (b) a fragment of the polypeptide of (a) which is antigenic itself or antigenic when provided as a hapten; (c) the fragment of (b) comprising an amino acid sequence selected from the group consisting of the amino acids 4-9, 15-26, 38-52, 65-76, 66-114, 108-115, 119-128 and 144-153 of SEQ ID No.422; and (d) the polypeptide or fragment of any of (a) to (c) in which at least one or only a few amino acids are exchanged, provided that the so modified peptide or fragment thereof are suited for eliciting an immune response in an individual vaccinated with a so modified polypeptide or fragment thereof.
Patent NZ-565782-A (NZ)
Title: Combination of reduced isoalpha acid isohumulones and an acacia extract for the treatment of metabolic syndrome / syndrome X
Inventor: TRIPP MATTHEW L
IPC: A61K36/48
Filed: 2006-08-09
Abstract: 565782 Disclosed is the use of a composition comprising a) a reduced isoalpha acid (such as dihydro-isohumulone, dihydro-isocohumulone, dihydroisoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydroisoadhumulone, hexahydro-isohumulone, hexahydro-isocohumulone, and hexahydroisoadhumulone); and b) a compound or extract derived from acacia (such as gum resin, bark powder, heartwood powder, or an Acacia catechu or Acacia nilotica extract); in the manufacture of a medicament for treating metabolic syndrome / syndrome X in a subject.
Patent NZ-568509-A (NZ)
Title: Cheese depleted in beta casein
Inventor: O'MAHONY JAMES ANTHONY
IPC: A23C9/142
Filed: 2006-10-27
Abstract: Disclosed is a cheese with improved meltability made by the process comprising: a) cooling milk to a temperature sufficient to release beta-casein from the micelles containing beta-casein; b) separating beta-casein from other milk proteins using a polymeric microfiltration membrane to form a retentate depleted in beta-casein; c) cooling the retentate depleted in beta-casein to a temperature sufficient to release beta- casein from the micelles containing beta-casein; d) separating the retentate depleted in beta-casein using microfiltration with diafiltration to obtain beta-casein-depleted milk protein concentrate; and e) using the beta-casein-depleted milk protein concentrate to produce cheese with improved meltability in comparison to corresponding manufactured cheese.
Patent NZ-574515-A (NZ)
Title: High frequency power transformer and method of forming
Inventor: HARRISON MICHAEL JOHN
IPC: H01F5/00
Filed: 2010-02-17
Abstract: A high frequency power transformer has first and second windings 513, 505 and a core 519 that encompasses at least the second winding. The second winding 505, 515, which is in the form of a conductive block, has first and second side portions 505 and a top portion 503 through which at least two winding apertures 509A, .,509D pass. The first winding 513, 523 passes through the apertures provided through the second winding.
Patent NZ-586179-A (NZ)
Title: Kite folding structure with central rod supporting tensioning trusses with foldable rods
Inventor: HARTASANCHEZ CASTILLO ROBERTO
IPC: A63H27/08
Filed: 2010-06-18
Abstract: Disclosed is a folding structure for kites, applicable in kites equipped with an internal structure based on rods assembled within the interior of a specific external part of the kite's fabric (1). It allows the kite to be folded and unfolded. It is characterized by the fact that the internal structure is complemented by a central longitudinal rod (2) running through the entire kite. The rod (2) supports various tensing trusses (3) with folding arms (4), which are movable in both directions and associated to a further range of rods (5), and which constitutes the folding structure of the kite.